Immunotherapy in RAS mutant mCRC: Could CTLA-4 blockade increase the efficacy of anti PD-1 agents? Preliminary clinical results of the NERDY study.

Authors

null

Alessandra Anna Anna Prete

Medical Oncology 1, Veneto Institute of Oncology IOV–IRCCS, Padua, Italy;

Alessandra Anna Anna Prete , Rossana Intini , Vittoria Matilde Piva , Valentina Angerilli , Francesca Daniel , Giulia Barsotti , Maria Caterina De Grandis , Krisida Cerma , Giada Munari , Gianmarco Ricagno , Aldo Montagna , Chiara De Toni , Silvia Rossi , Riccardo Cerantola , Cosimo Rasola , Francesca Schiavi , Matteo Fassan , Francesca Bergamo , Vittorina Zagonel , Sara Lonardi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 218)

DOI

10.1200/JCO.2023.41.4_suppl.218

Abstract #

218

Poster Bd #

L20

Abstract Disclosures

Similar Posters